Navigation Links
FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
Date:6/1/2009

dy. The most frequently reported adverse events (greater than or equal to 10 percent and twice placebo) in the dose optimization phase for patients taking VYVANSE were decreased appetite, insomnia, headache, irritability, upper abdominal pain, and affect lability (mood swings).

VYVANSE, which was introduced in the United States in July 2007 for the treatment of ADHD in children aged 6 to 12 years and approved in April 2008 to treat ADHD in adults, is currently available in six dosage strengths of 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. To date, more than 5 million VYVANSE prescriptions have been filled, bringing the current market share to 12 percent based on weekly branded prescription volume. Additionally, VYVANSE formulary coverage has been positive, with 10 of 11 top managed care plans covering the product in a preferred formulary position.

VYVANSE is a therapeutically inactive prodrug, in which d-amphetamine is covalently bonded to l-lysine, and after oral ingestion it is converted to pharmacologically active d-amphetamine. The conversion of VYVANSE to d-amphetamine is not affected by gastrointestinal pH and is unlikely to be affected by alterations in GI transit times.

Additional information about VYVANSE and Full Prescribing Information, including Medication Guide, are available at www.vyvanse.com.

About VYVANSE

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.


'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
2. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
3. Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. FDA Approves Label Change for Non-Invasive Fibroid Treatment
5. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
6. FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
7. FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
8. European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
9. Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects
10. FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
11. FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 AACC International unveiled the ... the grain scientists’ Centennial Meeting and also issued ... marks the 100th anniversary of AACC International (AACCI), ... Minnesota, U.S.A. on October 18-21, 2015. The meeting ... are looking to the next 100 years of ...
(Date:3/6/2015)... LYNBROOK, N.Y. , March 6, 2015 ... biopharmaceutical company developing first in class collagenase-based products marketed ... in the U.S. and XIAPEX ®  in the EU, ... and live audio webcast at 8:30 a.m. ET on ... and full year 2014 financial results and provide a ...
(Date:3/6/2015)... Anton Paar has released an application flash regarding ... Sodium hydroxide (NaOH, also known as lye or ... products including pretzels, colored fabrics, soap and aluminum foil. ... industry; its applications range from the food and beverage ... NaOH is used in the production of downstream ...
(Date:3/5/2015)... 2015  DuPont (NYSE: DD ) announced ... Conference held today in New York ... discussed strategy, progress and plans to accelerate growth ... and growing the company,s leading position in high-value advanced ... priority for DuPont. Discussing the company,s Advanced ...
Breaking Biology Technology:AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4
... expectant parents offered by Family Cord Blood Services, a ... a basic course on cord blood banking., WHEN/ ... Avenue (near Bundy and Olympic) Los Angeles, CA 90025 ... (Breakfast will be served), Space ...
... MANILA, Philippines, Feb. 13 After a ... ground with another year,of double-digit growth and new ... report released today by the International Service for ... crop,area grew 12 percent or 30.3 million acres ...
... Lentigen Corporation today,announced the company is moving ... University of Maryland Baltimore County,TechCenter to a ... Located along Maryland,s I-270 technology corridor, the ... as a leading,developer and manufacturer of lentiviral ...
Cached Biology Technology:FREE Infant CPR Training and Cord Blood Banking 101 for Expectant Parents 2Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 2Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 3Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 4Lentigen to Move Headquarters and Manufacturing to Gaithersburg 2
(Date:2/25/2015)... LITTLE ROCK, Ark. , Feb. 25, 2015 ... of software and billing in the Health and ... software as well as to MYiCLUBonline.  The latest ... MYiCLUBonline and the inclusion of cardless check-in via ... demonstrated for the first time through interactive displays ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... journal Science, researchers at the University of Texas Medical ... to a test that will enable medical science to estimate ... mad cow disease, which can take as long as 40 ... also help prevent accidental transmission of the malformed proteins that ...
... blackjack to investors picking stocks, humans make a ... versus reward. However, laboratory studies have not been ... information-processing "subcortical" regions of the brain function in ... and colleagues at the California Institute of Technology ...
... drinkers are familiar with the ring-shaped stains that result ... brown stain is not evenly distributed, but instead concentrated ... Wong, a professor of materials science and engineering, physics, ... has found the same "coffee-ring" formation in drying drops ...
Cached Biology News:Prion find points way to test for human 'mad cow' disease 2Brain's 'gambling circuitry' identified 2Brain's 'gambling circuitry' identified 3Ring-like formations in drying DNA drops could affect hybridization studies 2
... (Vesicle-Associated Membrane Protein 2, Synaptobrevin ... share homology with any other ... is expected that the antibody ... Macaca multata and bovine due ...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
Biology Products: